Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1052265 | 0.86 | POLB (0.40) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA | |
| SCHEMBL2983917 | 0.83 | CA1 (0.39) | CYP3A4CYP2C19GAACA1CA2 | |
| SCHEMBL6837614 | 0.83 | PPARD (0.38) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA | |
| SCHEMBL29533957 | 0.83 | GAA (0.39) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA | |
| SCHEMBL9651262 | 0.83 | GAA (0.42) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA | |
| SCHEMBL7216297 | 0.83 | GAA (0.39) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA | |
| SCHEMBL14355792 | 0.82 | CYP3A4 (0.37) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA | |
| SCHEMBL10451891 | 0.82 | CA1 (0.49) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA | |
| SCHEMBL28724497 | 0.80 | ACHE (0.38) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA | |
| SCHEMBL16501372 | 0.80 | CA1 (0.37) | CYP3A4CYP2C9CYP2C19L3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105330698-B | Loop coil aryl phosphorous oxides and sulfide | 齐鲁制药有限公司 | 2019-05-28 | — | — | CN | disclosed |
| EP-3165530-B1 | SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE | QILU PHARMACEUTICAL CO LTD (CN) | 2018-12-05 | — | — | EP | disclosed |
| US-10053477-B2 | Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide | QILU PHARMACEUTICAL CO., LTD. (CN) | 2018-08-21 | — | — | US | disclosed |
| US-9655879-B2 | Heteroarylcarboxylic acid ester derivative | EA PHARMA CO., LTD. (JP) | 2017-05-23 | — | — | US | disclosed |
| US-20170129909-A1 | SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE | QUILU PHARMACEUTICAL CO., LTD. (CN) | 2017-05-11 | — | — | US | disclosed |
| EP-3165530-A1 | SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE | Qilu Pharmaceutical Co., Ltd (CN) | 2017-05-10 | — | — | EP | disclosed |
| US-20160058734-A1 | HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2016-03-03 | — | — | US | disclosed |
| CN-105330698-A | Spiro aryl phosphorus oxide or sulfide | NANJING MINGDE DRUG R & D CO LTD | 2016-02-17 | — | — | CN | disclosed |
| US-9227949-B2 | Heteroarylcarboxylic acid ester derivative | AJINOMOTO CO., INC. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-20150248969-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, DYE-ADSORBED ELECTRODE, AND METHOD FOR PRODUCING DYE-SENSITIZED SOLAR CELL | FUJIFILM CORPORATION (JP) | 2015-09-03 | — | — | US | disclosed |
| EP-1637525-B1 | Benzoxazole compound, process for producing the same, and herbicides | KYOYU AGRI CO LTD (JP) | 2007-12-19 | — | — | EP | disclosed |
| CN-101084198-A | Substituted amino-pyrimidones and uses thereof | ASTRAZENECA AB (SE) | 2007-12-05 | — | — | CN | disclosed |
| CN-101084199-A | Substituted amino-compounds and uses thereof | ASTRAZENECA AB (SE) | 2007-12-05 | — | — | CN | disclosed |
| EP-1681287-A1 | Benzoxazole compounds, process for producing the same, and herbicides | Ube Industries, Ltd. (JP) | 2006-07-19 | — | — | EP | disclosed |
| EP-1681286-A1 | Benzoxazole compounds, process for producing the same, and herbicides | Ube Industries, Ltd. (JP) | 2006-07-19 | — | — | EP | disclosed |
| EP-1637525-A1 | Benzoxazole compound, process for producing the same, and herbicides | Ube Industries, Ltd. (JP) | 2006-03-22 | — | — | EP | disclosed |
| US-20050233909-A1 | Benzoxazole compounds, process for producing the same and herbicides | UBE INDUSTRIES, LTD. (JP) | 2005-10-20 | — | — | US | disclosed |
| US-6844295-B2 | Benzoxazole compound, process for producing the same, and herbicide | UBE INDUSTRIES, LTD. (JP) | 2005-01-18 | — | — | US | disclosed |
| US-20040014977-A1 | Benzoxazole compound, process for producing the same, and herbicide | KYOYU AGRI CO., LTD. (JP) | 2004-01-22 | — | — | US | disclosed |
| EP-1302466-A1 | BENZOXAZOLE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND HERBICIDE | Ube Industries, Ltd. (JP) | 2003-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150248969-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, DYE-ADSORBED ELECTRODE, AND METHOD FOR PRODUCING DYE-SENSITIZED SOLAR CELL | CHRM1, L1CAM, CRY1 | CYP3A4 2673/4885CYP2C9 2626/4885CYP2C19 3409/4885 |
| US-20170129909-A1 | SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE | ALK, ROS1, ARSA | CYP3A4 1469/4885CYP2C9 683/4885CYP2C19 579/4885 |
| US-20050233909-A1 | Benzoxazole compounds, process for producing the same and herbicides | CBR3, CBR1, CYP4X1 | CYP3A4 72/4885CYP2C9 35/4885CYP2C19 194/4885 |
| US-10053477-B2 | Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide | ALK, ROS1, ARSA | CYP3A4 1469/4885CYP2C9 683/4885CYP2C19 579/4885 |
| US-20040014977-A1 | Benzoxazole compound, process for producing the same, and herbicide | CBR1, CBR3, CYP4X1 | CYP3A4 65/4885CYP2C9 36/4885CYP2C19 241/4885 |
| US-20160058734-A1 | HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE | DPP4, DPP9, DPP7 | CYP3A4 145/4885CYP2C9 292/4885CYP2C19 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.